Need Help? Call 1­-866-­796-­7386
« back to stock screener

  RGEN stock: Repligen Corporation

Current Rating
Strong Sell

Previous Rating

Sell
Our Stock Ratings
double the S&P500!
Learn more.
Company Statistics
Price
$48.79
Market Cap
1.99B
Sector
Health Care
Div. Growth
-
P/E
96.7
P/B
3.44
P/S
13.2
Dividend %
-
P/CF
43.3
P/FCF
168.4
Op. Cash Flow
17.9K
FCF
0.2
Op. Margin
9.20%
Net Margin
18.50%
ROE
5.90%
ROI
3.70%
ROA
4.50%
EPS Growth
85.10%
Current Ratio
9.6
Debt/Equity
16.80%
Company Price P/E Div. Yield Market Cap ($Mil) Rating
Integer Holdings Corp (ITGR) $72.15 - - 2.05B Strong Buy
China Pharma Holdings, Inc. (CPHI) $0.24 - - 10M Strong Buy
Acorda Therapeutics Inc (ACOR) $28.75 - - 1.32B Strong Buy
AMAG Pharmaceuticals, Inc. (AMAG) $21.85 - - 683.1M Strong Buy
Opiant Pharmaceuticals Inc (OPNT) $15.25 - - 40.1M Strong Buy
Find great stocks now!
Avoid risky stocks
Enter your favorite tickers and click “Get Ratings”

Disclaimer

Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.

All analysis relies on publicly available financial information. Learn More